financetom
Business
financetom
/
Business
/
BRIEF-Diabetes Device Maker Embecta Explores Sale Amid Slowing Profits - FT
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Diabetes Device Maker Embecta Explores Sale Amid Slowing Profits - FT
Jul 19, 2024 4:10 PM

July 19 (Reuters) - Embecta Corp ( EMBC ):

* DIABETES DEVICE MAKER EMBECTA EXPLORES SALE AMID SLOWING

PROFITS

- FT

Source text https://tinyurl.com/y6ecfbp8

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday
Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday
Nov 12, 2024
09:10 AM EST, 11/12/2024 (MT Newswires) -- Consumer stocks were mixed pre-bell Tuesday with the Consumer Staples Select Sector SPDR Fund ( XLP ) up 0.2% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) 0.3% lower recently. Shopify ( SHOP ) shares rose 22% after the company reported higher Q3 revenue and set a mid-to-high-twenties percentage growth...
Disc Medicine's Q3 Net Loss Widens
Disc Medicine's Q3 Net Loss Widens
Nov 12, 2024
09:08 AM EST, 11/12/2024 (MT Newswires) -- Disc Medicine ( IRON ) reported a Q3 loss Tuesday of $0.89 per share, wider than a loss of $0.58 a year earlier. Analysts polled by Capital IQ expected a loss of $0.99. As expected, no revenue for the quarter ended Sept. 30 was reported. As of Sept. 30, the company had $487.4...
Greenlane Renewables Inks $6.5 Million Landfill Gas-to-RNG System Contract
Greenlane Renewables Inks $6.5 Million Landfill Gas-to-RNG System Contract
Nov 12, 2024
09:07 AM EST, 11/12/2024 (MT Newswires) -- Greenlane Renewables ( GRNWF ) on Tuesday said it has secured a $6.5 million contract from an unnamed customer to provide a new system for upgrading biogas produced at a landfill in Canada into pipeline-quality renewable natural gas (RNG). We're seeing traction on the further build out of RNG-producing facilities in Canada and...
Bicara Therapeutics' Q3 Loss Narrows
Bicara Therapeutics' Q3 Loss Narrows
Nov 12, 2024
09:06 AM EST, 11/12/2024 (MT Newswires) -- Bicara Therapeutics ( BCAX ) reported a Q3 net loss Tuesday of $1.60 per share, narrowing from a loss of $38.23 a year earlier. A single analyst polled by Capital IQ expected a loss of $0.43 per share. As of Sept. 30, the company said it had $520.8 million as cash and cash...
Copyright 2023-2026 - www.financetom.com All Rights Reserved